| Metric | შპს ჯი-ი-ეს-ეი ფარმაცევტიკალს | შპს თი-აი-დი ფუდს | შპს ნიუ ფარმ გრუპი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾5.7m₾5.5m | ₾5.5m₾3.7m | ₾5.5m₾4.6m |
| Revenue growth | 2.4% | 48.5% | 19.2% |
| Profitability | |||
| EBITDA | ₾2.7m₾1.7m | ₾357k₾691k | ₾1.6m₾1.2m |
| EBITDA margin | 48.4%30.1% | 6.4%18.5% | 28.1%25.7% |
| Net profit | ₾2.6m₾1.6m | ₾353k₾689k | ₾1.3m₾712k |
| Net margin | 46.4%29.8% | 6.4%18.5% | 23.9%15.3% |
| Balance sheet | |||
| Total assets | ₾13.5m₾10.6m | ₾4.2m₾3.4m | ₾4.3m₾3.3m |
| Total equity | ₾11.7m₾9.1m | ₾1.2m₾913k | ₾742k₾362k |
| ROE | 22.4%18.1% | 30.4%75.5% | 178.4%196.7% |